HomeNAV • CVE
add
Navco Pharmaceuticals Inc
Previous close
$0.040
Day range
$0.035 - $0.035
Year range
$0.020 - $0.18
Market cap
2.00M CAD
Avg Volume
29.87K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 263.86K | 187.21% |
Net income | -271.95K | -185.45% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -256.47K | -203.60% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 79.60K | 5,085.41% |
Total assets | 606.85K | — |
Total liabilities | 791.35K | — |
Total equity | -184.50K | — |
Shares outstanding | 40.35M | — |
Price to book | ∞ | — |
Return on assets | -85.74% | — |
Return on capital | -113.89% | — |
Cash Flow
Net change in cash
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -271.95K | -185.45% |
Cash from operations | -148.90K | -412.19% |
Cash from investing | — | — |
Cash from financing | -6.18K | 80.47% |
Net change in cash | -155.07K | -1,064.75% |
Free cash flow | -95.74K | — |
About
Headquarters
Website